Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CHEPLAPHARM logo — A Sustainable Platform for Specialty Pharma.

CHEPLAPHARM

A Sustainable Platform for Specialty Pharma.

Founded 1998 Germany Greifswald, Germany 518 employees Post-IPO Debt Health Care, Health and Wellness +2

General Information

Company Name CHEPLAPHARM
Founded Year 1998
Location Germany Greifswald, Germany
Employees 518
Industries Health Care, Health and Wellness, Pharmaceutical +1
Funding Stage Post-IPO Debt
Business Model B2B, Platform, B2B2B
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with CHEPLAPHARM. To contact CHEPLAPHARM, visit cheplapharm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CHEPLAPHARM compare?

A PDF of CHEPLAPHARM and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CHEPLAPHARM soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CHEPLAPHARM

CHEPLAPHARM, founded in 1998 and headquartered in Germany, has positioned itself as a pivotal player in the Health Care and Pharmaceutical industry. Operating globally, the company prides itself on its sustainability-focused platform for specialty pharma.

With the slogan "A Sustainable Platform for Specialty Pharma," CHEPLAPHARM strategically invests in established pharmaceutical brands originally developed by research-intensive companies. This allows these firms to redirect their resources towards innovation and developing new products, while CHEPLAPHARM ensures the continued value and impact of these legacy brands. Their expertise benefits both patients and the broader medical community.

Currently, there is no record of recent external investment activity. For investors, CHEPLAPHARM represents a stable entity grounded in a proven business model with potential opportunities for consolidating mature drug portfolios in the evolving pharmaceutical landscape.

Business keywords: Specialty Pharma, Pharmaceutical Brands, Heart Conditions, Cancer Treatments, Infectious Diseases, Diversified Portfolio, Therapeutic Areas, Brand Investment, Pharmaceutical Divestiture, Medical Community Support, Branded Drugs, Medical Products, Supplements, Cosmetics, Healthcare Innovation Support

Services & Products

Investment in pharmaceutical brands
Development of legacy pharma products
Supply chain enhancement
Pharmaceutical product safety assurance
Investor and creditor relations

Target Customers

Pharma companies looking for brand development Healthcare providers Investors seeking sustainable growth Pharmaceutical distributors Patients needing established pharmaceutical products

No funding data available for CHEPLAPHARM yet.

CHEPLAPHARM Alternatives & Competitors

View All Alternatives
CHEPLAPHARM vs
Daiichi Sankyo Japan
Daiichi Sankyo Japan Japan

Passion for Innovation. Compassion for Patients.

1708 employees
Biotechnology, Health Care
CHEPLAPHARM vs
ADVANZ PHARMA
ADVANZ PHARMA United Kingdom

Partner of choice in specialty, hospital, and rare disease medicines

Post-IPO Equity
734 employees
Health Care, Pharmaceutical
Compare CHEPLAPHARM vs ADVANZ PHARMA
CHEPLAPHARM vs
Bausch Health Companies Inc.
Bausch Health Companies Inc. Canada

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global, diversified health care company that devel...

Post-IPO Debt
2720 employees
Biotechnology, Health Care
View all alternatives

FAQ About CHEPLAPHARM

A Sustainable Platform for Specialty Pharma.
CHEPLAPHARM was founded in 1998.
CHEPLAPHARM is headquartered in Greifswald, Germany.
CHEPLAPHARM operates in Health Care, Health and Wellness, Pharmaceutical and Wellness Beauty. Its work centres on Specialty Pharma, Pharmaceutical Brands, Heart Conditions and Cancer Treatments. Its customers include Pharma companies looking for brand development, Healthcare providers and Investors seeking sustainable growth.
CHEPLAPHARM has a B2B, Platform and B2B2B business model. Its revenue comes from Product Sales, Licensing and Service Fee.
CHEPLAPHARM has approximately 518 employees.
CHEPLAPHARM offers: Investment in pharmaceutical brands, Development of legacy pharma products, Supply chain enhancement, Pharmaceutical product safety assurance, Investor and creditor relations.
Top alternatives and competitors to CHEPLAPHARM include Daiichi Sankyo Japan, ADVANZ PHARMA, Bausch Health Companies Inc., good healthcare group, Alvita Pharma Private Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CHEPLAPHARM and Daiichi Sankyo Japan are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CHEPLAPHARM, https://bouncewatch.com/company/cheplapharm, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes